Page last updated: 2024-08-23

bis(4-methyl-1-homopiperazinylthiocarbonyl)disulfide and Dyskinesia Syndromes

bis(4-methyl-1-homopiperazinylthiocarbonyl)disulfide has been researched along with Dyskinesia Syndromes in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bruinvels, J; Cools, AR; van der Laan, JW1
Dolphin, A; Jenner, P; Marsden, CD1

Other Studies

2 other study(ies) available for bis(4-methyl-1-homopiperazinylthiocarbonyl)disulfide and Dyskinesia Syndromes

ArticleYear
Dipropylacetate-induced quasi-morphine abstinence behaviour in the rat: participation of the locus coeruleus system.
    Brain research, 1982, Sep-16, Volume: 247, Issue:2

    Topics: Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Disease Models, Animal; Humans; Locus Coeruleus; Male; Morphine; Movement Disorders; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Valproic Acid

1982
Proceedings: The mechanism of the effect of dopamine-beta-hydroxylase inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia.
    British journal of pharmacology, 1975, Volume: 54, Issue:2

    Topics: Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Dopamine beta-Hydroxylase; Imidazoles; Levodopa; Mice; Motor Activity; Movement Disorders; Reserpine; Time Factors

1975